MRC1 and cancer: Moreover, flow cytometric analysis showed significant increases in the percentage of CD206+, but not CD80+ macrophages, when they were stimulated with the CM from SA/Dox-treated cancer cells as compared to that of the macrophages stimulated with the CM from control cancer cells (Fig. 6G).